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Histopathologic findings associated with a chronic, progressive decline
in renal allograft function. The relationship between specific histopatho-
logic findings of chronic rejection (CR) and the clinical course of renal
transplant recipients with a chronic progressive decline in allograft
function (CPDAF) is unknown. We used one or two hinged regression
lines, fitted by least-squares to serial creatinine clearances, to define the
onset and clinical course of CPDAF. Biopsies (N = 100) from patients
transplanted from 1978 to 1982 were studied retrospectively. Interstitial
fibrosis, tubular atrophy, and fibrointimal arterial narrowing were more
pronounced in biopsies obtained after, but not before the onset of
CPDAF. Interstitial hemorrhage, an infrequent finding in acute vascular
rejection, preceded the onset of CPDAF, but the more common
histologic findings of acute cellular rejection did not. The severity of
histologic features of CR (as reflected by a score combining fibrointimal
arterial narrowing, interstitial fibrosis, tubular atrophy, glomerular
sclerosis, glomerular mesangial expansion, and glomerular basement
membrane reduplication) correlated with the duration of subsequent
allograft survival (r = —0.65, P < 0.001). Glomerular size increased
after transplantation, but was not different in patients with or without
CPDAF, suggesting that mechanisms related to compensatory hyper-
trophy did not play a major role in the pathogenesis of CR. In summary,
the histologic findings of CR did not predict the onset of CPDAF, did
not distinguish whether the pathogenesis was mediated by immune or
nonimmune events, but did correlate with the duration of subsequent
allograft survival.
Acute renal allograft rejection is characterized by a rapid
deterioration in function and histologic findings that often
predict the clinical course and the response to treatment [1—61.
Chronic rejection (CR) is histologically distinct from acute
rejection [7—12], and responds poorly to treatment [12—15].
Although combined patient and allograft survival was recently
shown to be reduced in patients with CR [5], few studies have
systematically examined the clinical course of patients whose
allograft biopsy showed CR. As a result, several questions
remain unanswered, Specifically, it is not known how often the
histologic features of CR precede, and thus potentially predict a
chronic, progressive decline in renal allograft function
(CPDAF). It is possible that the histologic findings of CR may
only occur after a substantial amount of function has been lost,
in which case such findings would have little predictive value.
Also unclear is how well the histologic findings of CR correlate
with the subsequent functional decline, and whether CR is
compatible with long-term graft survival. In this regard, some
descriptions of CR were from patients who lost their grafts
within the first few weeks after transplantation [71, suggesting
that a biopsy diagnosis of CR may not always imply that the
subsequent clinical course will be chronic. Finally, the fre-
quency with which hypertension, proteinuria, and other clinical
parameters precede or accompany the histologic findings of CR
has not been well documented.
We used serial creatinine clearances (Car) and curve-fitting
techniques to define the incidence, time of onset, and clinical
course of CPDAF in patients who survived with a functioning
allograft for at least one year after transplantation [16]. In the
present study, the results of biopsies obtained before and after
onset of CPDAF were compared with those from biopsies
obtained early and late in the course of control patients who had
only acute declines, or maintained stable allograft function. In
addition, the relationship between renal function, hypertension,
proteinuria and specific histologic findings of CR were exam-
ined.
Methods
Patients
The 100 biopsies analyzed in the present study were obtained
from 74 patients included in a larger group of transplant
recipients whose clinical course has previously been described
[16]. All patients were transplanted between January, 1978, and
August, 1982, and had allografts that functioned for one year or
longer. Patients were followed until January 1, 1990. The
immunosuppression protocol utilized Minnesota antilympho-
cyte globulin, corticosteroids, and azathioprine, as previously
described [16]. All but one patient had undergone splenectomy
prior to transplantation, and all but two transplants were from
cadaver donors. None of the patients were treated with cyclo-
sporine.
Allograft function
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The baseline Cr was measured 5 4 months before biopsy.
The change in C. immediately before biopsy was calculated as
the difference between the Cr at the time of biopsy and the
baseline Car. The change in Cr by 5 4 months after biopsy
514
Kasiske et al: Histopathology in chronic renal al/ograft rejection 515
0
-4-
0 12 24 36 48 60 72 84
Time, months after transplantation
Fig. 1. The clinical course of a typical patient with a chronic, progres-
sive decline in allograft function is shown. The patient had an acute,
irreversible decline in Cr 46 months after transplantation. The function
lost during this acute rejection episode was added back to the baseline
Ccr to permit an analysis of chronic changes in renal function. The open
circles show the actual Ce,. values after the acute decline in function.
The solid circles show the Cr values before the acute rejection episode,
and the Cr values corrected for the acute, irreversible decline in
function that was associated with the acute rejection episode. Regres-
sion analysis showed that two hinged lines fitted the data better than a
single line, and that the onset, or breakpoint, occurred at about the time
of the acute rejection episode.
was calculated as the difference between the C. after biopsy
and the Cr at the time of biopsy. Chronic trends in allograft
function were analyzed using Ce,. and interim serum creatinine
levels as previously described [16]. The serum creatinines for
this analysis were obtained monthly. The Cr measurements
were made routinely at 3, 6, 9, 12, 18, 24 months, and yearly
thereafter. Additional Cr measurements were obtained when
there was a change in serum creatinine. After correcting for
acute, irreversible changes in CC. that occurred within a three
month time period, the chronic course of declining renal func-
tion was modeled as the best 1, or 2, least-squares-fitted,
hinged, regression lines using the method of Jones and Molitoris
(Fig. 1) [16, 17].
Biopsies
At our center, the first acute decline in allograft function
(manifested by at least a 30% decrease in Ccr) was empirically
treated with intravenous corticosteroids. A decline in function
that did not reverse with treatment, or a second decline in
function (acute or chronic) was used as an indication for biopsy.
In addition, biopsies were also obtained for urine protein
excretion greater than 1.0 g/24 hr. Cases of recurrent or
secondary glomerular disease, for example, type II membra-
noproliferative glomerulonephritis, diabetic nephropathy or
systemic amyloidosis, were not included in the analysis. Of the
100 biopsies that were studied, 44 were from 29 patients with
CPDAF and ,56 were from 45 control patients who had a stable
clinical course or an acute decline in function. For analysis, the
biopsies were divided into four groups: 1) 13 biopsies were
obtained before the onset of CPDAF (within the first nine
months after transplantation); 2) 31 were obtained after the
onset of CPDAF; 3)11 biopsies were obtained within the first
nine months after transplantation in control patients who did
not have CPDAF; and 4) 45 were obtained later in the post-
transplant period in patients who did not have CPDAF.
Renal histology
Tissue for light microscopy was fixed in 10% buffered form-
aldehyde and embedded in paraffin. Sections were stained with
hematoxylin-eosin, Masson's trichrome, and Jones' modifica-
tion of the periodic acid-methenamine silver stain. All biopsies
were examined independently, and in a blinded fashion, by two
investigators. For each specimen, 16 histologic features were
evaluated, For each feature, the investigator indicated the
degree of involvement by placing a mark on a continuous 0 to
100 scale. On this scale, 0 represented normal, or no involve-
ment, and 100 represented the greatest amount of involvement.
For each individual histologic parameter, a mean score was
computed from the separate scores of the two investigators.
The individual features evaluated were: 1) interstitial edema;
2) interstitial fibrosis; 3) acute, interstitial, mononuclear cell
infiltration; 4) interstitial hemorrhage; 5) glomerular capillary
endothelial swelling and proliferation; 6) glornerular mesangial
expansion; 7) glomerular polymorphonuclear cell infiltration; 8)
necrosis of glomerular tufts; 9) vascular (arterial or arteriolar)
necrosis; 10) vascular endothelial cell swelling and prolifera-
tion; 11) chronic, fibrointimal arterial lumen encroachment; 12)
fibrin thrombi in glomerular or interstitial capillaries; 13)
chronic tubular atrophy and loss; 14) glomerular basement
membrane splitting, or reduplication; and 15) epimembranous
deposits. In addition, the percent of glomeruli which were
completely hyalinized was determined.
Mean glomerular areas were determined using planar mor-
phometry. The perimeter of Bowman's capsule was traced
using a video camera and a computerized, digital image analysis
system (Southern Micro Instruments, Inc., Atlanta, Georgia,
USA). The integrated area within the perimeter was then
computed. The mean glomerular area was the arithmetic mean
of the individual measurements in each specimen. Sclerotic
glomeruli were not measured.
Immunofluorescence, and electron microscopic studies were
also available in most cases. The results of these studies were
used to confirm specific biopsy findings noted on light micros-
copy, such as, the presence or absence of epimembranous
deposits. Thus, immunofluorescence and electron microscopy
results were used only indirectly in the semiquantitative scoring
and analysis.
Hypertension and proteinuria
Blood pressure was measured 5 4 months before, at the
time of, and 5 4 months after biopsy. Blood pressure was
expressed as mean arterial pressure: (MAP) = ('/3 x (systolic-
diastolic)) + diastolic. For patients receiving antihypertensive
medications, blood pressure measurements alone could not
adequately reflect the degree of hypertension. Therefore, a
Hypertension Index was calculated to take into account both
the MAP and the number of antihypertensive medications that
were being used when the MAP was measured: Hypertension
Index = N + [(MAP — 93)/20], where N was the number of
different types of antihypertensive medications, including di-
uretics, being used. Thus, for a patient receiving no antihyper-
tensive medications whose blood pressure was 120/80 mm Hg
(MAP = 93 mm Hg) the Hypertension Index was 0. At the same
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time that Cr and blood pressure were determined, 24-hour
urine protein excretion was also measured.
Statistical analysis
Each study variable was examined using indices of kurtosis
and skewness, and the Kolmogorov-Smirnov test to determine
which distributions were Gaussian. Variables that required
logarithmic transformation to achieve a normal distribution
prior to analysis included the glomerular area and glomerular
polymorphonuclear cell infiltration. Variables that were not
normally distributed, even after appropriate transformation,
included the percent of glomeruli with partial or total sclerosis,
interstitial hemorrhage, capillary endothelial cell swelling and
proliferation, necrosis of glomerular tufts, vascular necrosis,
vascular endothelial cell swelling and proliferation, capillary
fibrin thrombi, glomerular basement membrane splitting, and
epimembranous deposits. However, when these non-Gaussian
measures were added to other Gaussian and non-Gaussian
measures, the resulting composite scores were normally distrib-
uted.
The significance of differences between groups was assessed
using Student's t-test or, in the case of multiple groups, one way
analysis of variance (ANOVA) with Duncan's multiple range
comparison test. To test group differences for non-parametric
variables, the Kruskal-Wallis test was used. Differences in
proportions were analyzed using the chi-square test. The sig-
nificance of linear associations between two parametric varia-
bles was assessed using the method of Pearson. Multivariate,
linear regression analysis was also used to determine which
clinical parameters were independently associated with his-
tologic findings of CR. All differences were considered signifi-
cant for P < 0.05. The results of parametric data are expressed
as mean SD. Nonparametric data are expressed as the mean
and range. The analysis was carried out using the Statistical
Package for the Social Sciences iSI.
Results
Patient characteristics
Between the patients who developed CPDAF and controls,
there were no statistically significant differences in age, sex, the
prevalence of diabetes, the number of major histocompatibility
mismatches at the A or B locus, the percent panel reactive
antibodies, the incidence of post-transplant acute tubular ne-
crosis, or other clinical characteristics (Table 1). Interestingly,
the number of packs of cigarettes smoked daily, multiplied by
the number of years smoked (pack-years), was greater at the
time of transplant in patients who subsequently had a progres-
sive decline in function. The outcome associated with histolog-
ical findings in patients with CPDAF was substantially worse
compared to the outcome associated with histological findings
from controls (Fig. 2). The times that the biopsies were ob-
tained were similar in patients with CPDAF versus controls
(Table 2).
Histopaihologic features
There were 12 14 glomeruli in each tissue specimen, and
there were no differences in the number of glomeruli in speci-
mens from patients who did or did not have CPDAF. Chronic
arterial fibrointimal narrowing, arterial intimal proliferation,
Table 1. Clinical characteristics of patients who did or did not have a
chronic, progressive decline in allograft function
Progressive No progressive
decline in decline in
function function
Characteristic Yes (N = 29) No (N = 45)
-
Diabetic patients % 31.0 17.8
Second transplant % 10.3 11.1
Males % 55.2 57.8
Native kidneys present % 48.3 55.6
Post-transplant acute tubular 44.8 46.7
necrosis %
Highest panel reactive antibodies 6.9 13.3
>50% %
Current panel reactive antibodies 3.4 4.4
>50% %
Smoked 5 pack-years at 65.5 42.2a
transplant %
Age at transplantation years 37 13 40 13
Age of donor kidney years 26 12 26 Il
Number of AB mismatches 1.4 0.6 1.5 0.7
Number of acute rejections 2.8 1.4 2.1 1.
Died % 10.3 24.4
Returned to dialysis % 793 0Øb
Values are means SD or percents.
a p < 0.05, b p < 0.001
interstitial fibrosis, glomerular mesangial expansion, tubular
atrophy, and a composite CR score were increased in biopsies
obtained after the onset of CPDAF (Table 3, Fig. 3). However,
these histologic findings were not increased in biopsy speci-
mens obtained before the onset of CPDAF (Table 3). Similar
results were observed regarding the proportions of biopsies
showing glomerular capillary basement membrane reduplica-
tion (Table 3). The number of completely hyalinized glomeruli
increased with time after transplantation, but was not different
in patients with and without CPDAF (Table 3). Only two
biopsies had a significant number of subepithelial deposits; one
was in a patient with, and one was in a patient without CPDAF.
The slope of the regression relationship between the degree
of arterial intimal narrowing and the time after transplantation
was greater in patients with CPDAF than in control patients
(Fig. 4). The intercepts, however, were the same in the two
groups (Fig. 4). Thus, arterial fibrointimal narrowing was more
severe late in the course of CPDAF, but early after transplan-
tation this histologic parameter was not different in patients
who did or did not have CPDAF.
The histopathological findings characteristic of acute cellular
rejection, such as, interstitial edema and mononuclear cell
infiltrates, were similar in patients with CPDAF and in controls
(Table 3). Likewise, a composite acute cellular rejection score
was similar in patients with and without CPDAF.
Biopsy findings possibly indicative of acute vascular rejection
occurred infrequently and the corresponding mean histologic
scores were low (Table 4). Segmental glomerular necrosis was
seen in 4 of 44 biopsies of patients with CPDAF versus 3 of 56
biopsies from patients with stable function, vascular necrosis
occurred in I of 44 biopsies of patients with CPDAF versus 1 of
56 biopsies in patients with stable function, and capillary
thrombi occurred in 2 of 44 biopsies of patients with CPDAF
versus 3 of 56 biopsies of patients with stable function. More-
over, the differences in glomerular necrosis, vascular necrosis,
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Fig. 2. Clinical outcome associated with biopsies
performed early after transplantation, that is, before
the onset of a chronic progressive decline in
allograft function (upper left panel), after the onset
of a chronic progressive decline in allograft function
(lower left panel), early after transplantation in
control patients (upper right panel), and late after
transplantation in control patients (lower right
panel).
Table 2. Renal function, blood pressure, and proteinuria associated with biopsies obtained from patients with and without a chronic,
progressive decline in allograft function
Progressive decline in function No progressive dccline in function
Early (N = 11) Late (N = 45)Early (N =13) Late (N = 31)
Time of biopsy months post-transplant
Ccr 5 4 months before biopsy mI/mm
Change in Cr before biopsy mI/mm
Change in Cr after biopsy mI/mm
Mean arterial pressure mm Hg
Hypertension Index
Urine protein >1.0 g/24hr%
4 2
75 l9
—37 3l20 l5
118 ll
2.2 l.4
2/13 (l5%)
45 2b
58 26"
—23 18
—3 12'-'
113 l4
2.5 l.8
10/30 (33%)
4 3
71 25a,b
—22 29
15 24a
ill ja
2.3 1.3
Jill (9%)
43 3b
75 22
—25 25
6 20b.c
109 16
1.9 l.7
8/45 (18%)
Values are mean sr except where indicated. Shared superscripts indicate P> 0.05.
Abbreviation is: Ccr, creatinine clearance.
and capillary thrombi scores between patients with and without
CPDAF were not statistically significant (Table 4). Glomerular
endothelial cell swelling was more common in early biopsies,
but it was also similar in patients with and without CPDAF
(Table 4). Although it was an infrequent finding, interstitial
hemorrhage was observed more often early (4 of 13) compared
to late (1 of 31) in biopsies from patients with CPDAF, and
compared to biopsies from control patients early (1 of 11) and
late (1 of 45) after transplantation (P < 0.01). Moreover, the
interstitial hemorrhage score was greatest in biopsies obtained
before the onset of CPDAF (Table 4). The composite acute
vascular rejection score was increased in biopsies obtained
early after transplantation in patients with and without CPDAF.
When the acute vascular rejection scores from early biopsies
were analyzed separately, there was a significant difference
between patients who subsequently developed CPDAF, 37
(range 0 to 101), and those who did not develop CPDAF 24
(range 0 to 80; P < 0.01).
Glomerular area
Glomerular areas increased with time after transplantation.
However, there were no differences in glomerular areas from
biopsies of patients with CPDAF compared to those from
controls (Table 3, Fig. 5). Glomerular areas were not different in
biopsies from patients with diabetes (Ln Area 8.85 0.44)
compared to biopsies from patients without diabetes (8.89
0.58).
Correlations between histopathology and rena/function
The Cr at 5 4 months before biopsy was lower in patients
with CPDAF compared to controls, but the reduced renal
function was evident only in patients who had biopsies in the
Alive
Died = 0
Chronic decline-early (N = 13) Controls-early (N = 11)
Alive
Chronic decline-late (N = 31) Controls-late (N 45)
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Table 3. Histopathologic findings in patients who had a chronic, progressive decline in allograft function or a stable clinical course
late post-transplant period (Table 2). Although the differences
were not statistically significant, there was a tendency for the
acute decline in C. before biopsy to be greater in patients
destined to develop CPDAF compared to that seen in controls
(Table 2). Biopsy findings typical of CR increased with time
after transplantation (Table 5). Histologic findings of CR were
also more marked in patients with lower baseline C. before
biopsy (Table 5). Likewise, CCr declined immediately after
biopsy in patients with CPDAF who underwent biopsy late, but
not in patients with CPDAF who underwent biopsy early, and
not in controls (Table 2).
Biopsy parameters of acute cellular rejection changed little
with time after transplantation (Table 5). Not surprisingly, a
greater amount of interstitial edema, or a higher composite
acute cellular-rejection score, were associated with a greater
acute decline in renal function before biopsy (Table 5). The
magnitude of the decline in before biopsy was also greater
in patients who had interstitial hemorrhage ( 45 36 mI/mm,
N = 7) compared to those who did not (—25 23 mI/mm, N =
93, P < 0.05). The differences in the decline in Cr before
biopsy between patients who had or did not have glomerular
necrosis (N = 6), vascular necrosis (N = 1), or capillary
thrombosis (N = 4) were not statistically significant (data not
shown).
Diabetes and histopathologic findings
There were 24 biopsies obtained from 17 diabetic patients in
the present study. When biopsy findings from diabetics were
compared to those from non-diabetics, no differences were
found. In particular, the glomerular mesangial expansion score
was 10 lOin diabetics versus 14 11 in controls (P > 0.05),
The fibrointimal arterial occlusion scores were 38 25 and 31
26 in diabetics and nondiabetics, respectively (P > 0.05).
Correlations between histopathology, hypertension and
proteinuria
The univariate regression analysis showed that few clinical
parameters correlated with the histopathologic findings charac-
teristic of acute cellular rejection. A multivariate regression
analysis was also carried out using the composite acute cellular
rejection score as the dependent variable, and multiple clinical
parameters as independent variables. None of the variables
examined had a statistically significant impact on the acute
cellular rejection score including: the time of biopsy after
transplant, the number of acute rejection episodes between the
time of transplant and the time of biopsy, the number of A or B
major histocompatibility antigen mismatches, the presence of
preformed antibodies, and acute tubular necrosis post-trans-
plant.
A number of clinical parameters were associated with his-
tologic findings of CR. Most closely correlated with the com-
posite CR score was the time of biopsy (Table 5). However,
there was also a strong correlation between the CR score and
the number of acute rejections before the time of biopsy (r =
0.47, P < 0.001). The Hypertension Index also correlated with
the CR score (r = 0.38, P < 0.001 before biopsy, r = 0.33, P <
0.001 at the time of biopsy, and r = 0.26, P <0.05 after biopsy).
The proportion of patients with urine protein excretion greater
than I .0 g/24 hr was almost twofold greater in patients with
CPDAF compared to controls, but this difference was not
statistically significant (Table 2). Nevertheless, patients with
urine protein excretion greater than 1.0 g/24 hr had more
intrarenal vascular damage, interstitial fibrosis, glomerular
basement membrane reduplication and subepithelial deposits
compared to patients who did not have proteinuria (Table 6).
Multivariate analysis was carried out using the CR score as
the dependent variable, and multiple clinical parameters as
independent variables. Post-transplant variables known to be
associated with chronic renal damage, such as proteinuria and
hypertension, were excluded from this analysis to avoid param-
eters that could have been the result rather than the cause of
CR. Interestingly, the time of biopsy, the number of acute
rejection episodes before biopsy and cigarette smoking were
each independently correlated with the CR score = 0.20(MO) +
4.00(AR) + 0.1 3(PY) + 16.23, where MO was the time of biopsy
in months post-transplant, AR was the number of acute rejec-
tion episodes before biopsy, and PY was the number of pack-
years of cigarettes smoked at the time of transplant. These
variables explained 41% of the variability in the CR score (P <
0.001). Variables that had no impact on the CR score included
Histologic finding
Progressive decline in function
Early (N = 13) Late (N = 31)
No progressive decline in function
Early (N = II) Late (N = 45) Overall Pvalue
I. Interstitial edema 38 17" 38 14" 33 18" 38 15" 0.847
2. Interstitial cells 39 14" 46 21" 38 19" 44 18" 0.527
3. Glomerular mesangial expansion 9 11" 18 I4' 10 9" 11 7" 0.009
4. Chronic arterial intimal occlusion 23 23" 47 27 20 18" 34 23" 0.003
5. Interstitial fibrosis 37 14" 63 38 16" 48 13" <0.001
6. Tubular atrophy 21 17" 51 16" 21 16" 35 16" <0.001
7. Glomerular area (Ln, square microns) 8.5 0.4" 9.1 0.7" 8.7 04a.b 9.0 0.5" 0.016
8. Arterial intimal proliferation 4 (0—36) 31 (0—85) 1 (0—12) 18 (0—74) <0.001
9. Glomerulosclerosis % 2 (0—25) 15 (0—75) 1 (0—13) 8 (0—86) 0.008
10. Basement membrane reduplication I (0—17) 29 (0—98) 0 (0) 8 (0—84) 0.001
II. Glomerular neutrophil infiltration 8(0—24) 15(0—46) 13(0—25) Il (0—SI) 0.415
12. Acute cellular rejection score (I + 2) 76 + 24" 83 + 30"
13. Chronic rejection score 93 43" 223 69"
71 33"
90 54°
82 29"
115 ÷ 6lC
0.639
<0.001
(3 + 4 + 5 + 6 + 9 + 10)
Values are mean + so, or, in the case of non-parametric data, ranges (in parentheses).
a.b.c Shared superscripts indicate P > 0.05 by analysis of variance and Duncan's multiple range comparison test
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Fig. 3. Biopsy findings associated with a chronic, progressive decline in allograft function. A Mild-moderate interstitia]L fibrosis (Masson's
trichrome). B Marked interstitial fibrosis, acute interstitial infiltrate, and mild fibrointimal arterial disease (hematoxylin-eosin). C Severe,
fibrointimal. occlusive arterial disease (Jones' modification of the periodic acid-methenamine silver stain). D Severe fibrointimal, vascular
occlusive disease with several hyalinized glomeruli, and a marked degree of interstitial fibrosis (hematoxylin-eosin). Original magnification: 400x
in panel A, 200x in panels B, C. and D.
the number of A or B major histocompatibility antigen mis- Ilistopathologic correlates of subsequent graft survival time
matches, the presence of preformed antibodies, age, donor age,
sex, donor sex, diabetes, the occurrence of acute tubular The 46 patients who returned to dialysis during the study
necrosis after transplantation or the presence of systemic period were analyzed separately to examine how well allograft
cardiovascular disease at the time of transplant. histology correlated with the duration of subsequent graft
0ci0
E
5)t
Fig. 4. The degree offibrointimal arterial occlusion
in patients who had a chronic progressive decline in
allograft function (CPDAF) (upper left panel; score
= 0.47 (T) + 24, where T = months after
transplantation, P < 0.0/) and in control patients
(upper right panel; score = 0.15 (T) + 26, P = 0.11).
The slopes were significantly different indicating a
more rapid increase in the degree of vascular
occlusion after transplantation in patients with
CPDAF. The intercepts were not different, indicating
that the degree of chronic vascular disease in
biopsies obtained early after transplantation failed to
predict patients who developed CPDAF. The degree
of interstitial fibrosis in patients who had CPDAF
(lower left panel; score = 0.44 (T) + 41, P < 0.001)
and in control patients (lower right panel; score =
0.15 (T) + 41, P <0.05).
Table 4. Histopathologic findings possibly indicative of acute vascular rejection in patients who had a chronic progressive decline in allograft
function or a stable clinical course
Histologic finding
Progressive dcclinc in function No progressive dedine in function Overall P
Early (N = 13) Late (N = 31) Early (N = 11) Late (N 45) value
1. Interstitial hemorrhage 4 (0—18) 0 (0—2) 0 (0—1) I (0—23) 0.003
2. Glomerular endothelial swelling 25 (0—87) 11(0—58) 22 (0—68) 6 (0—72) 0.027
3. Glomerular necrosis I (0—7) 1 (0—19) 2 (0—12) 2 (0—77) 0.277
4. Vascular necrosis 5 (0—60) 0 (0) 0 (0) 1 (0—41) 0.385
5. Capillary thrombosis 3 (0—24) 0 (0) 0 (0) 2 (0—80) 0.143
6. Acute vascular rejection score 37 (0—101) 12 (0—58) 24 (0—80) 11(0—200) 0.004(1 + 2 + 3 + 4 + 5)
Values are means and (in parentheses) ranges.
survival. Findings characteristic of acute cellular rejection were
not associated with the number of months remaining before
patients resumed dialysis (Table 6). The time remaining until
return to dialysis was also similar in patients with and without
biopsy findings of acute vascular rejection. For example, among
patients who returned to dialysis, the survival time after biop-
sies showing interstitial hemorrhage (N = 5) was 41 27
months compared to 31 27 months (P> 0.05) if biopsies did
not have interstitial hemorrhage (N = 41). The survival after
biopsies showing any feature of acute vascular rejection (N =
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Table 5. Relationship (r values) between the time of biopsy, renal function, and histopathologic findings
Histopathologic features
Time of biopsy
months after transplant
Ccr 5
bef
4 months
ore biopsy
mi/mm
Change in Ccr
before biopsy
%
Change in Cr
after biopsy
%
Interstitial edema —0.12 027b 0.14
Interstitial cells —0.04 0.11 —0.10 —0.10
Glomerular mesangial expansion 0.17 0.02 0.04
Chronic arterial intimal thickening
Interstitial fibrosis
031b
0.45' —O.35'
0.13
0.14 —O.27'
Tubular atrophy 0.35 —0.16 0.01 —O.28'
Glomerular aread 0.45 0.25 0.10 —0.06
Acute cellular rejection scoree
Chronic rejection scoree
—0.09
0.56c
O.22a 027b
0.09
0.01
030b
a P < 0.05, b P < 0.01, ' P < 0.001
d Glomerular areas were logarithmically (Ln) transformed
e Acute cellular and chronic rejection scores are defined in Table 3
23) was 30 26 months compared to 34 29 months (P> 0.05)
if biopsies had no features of acute vascular rejection (N =23).
In contrast, the histopathologic features of CR were highly
correlated with the subsequent graft survival time. The best
predictor of the duration of subsequent graft survival was the
composite CR score (Table 6).
Discussion
Over the past three decades great strides have been made in
the prevention and treatment of acute renal allograft rejection.
The success of this effort has led to a substantial decrease in
early allograft failure and patient mortality. However, with the
reduction in the incidence of acute rejection episodes and early
graft failure, CR and late graft loss have become increasingly
problematic [19].
While several investigations have correlated biopsy findings
with the course and outcome after acute rejection [l—6], few
studies have examined the relationship between the renal
histology of CR and the clinical course of declining allograft
function. In some investigations, fibrointimal arterial lesions
seen within the first three months after transplantation were
associated with rapidly progressive allograft failure [71.On the
other hand, similar arterial lesions have been found in allograft
biopsies obtained in the late post-transplant period [8—10]. The
frequency with which fibrointimal arterial occlusion and other
histologic findings of CR are associated with CPDAF has not
been well defined.
In the present investigation histologic findings of CR were
seen after, but not before, the onset of CPDAF. The histopatho-
logic findings that were most closely associated with CPDAF
were interstitial fibrosis, glomerular mesangial expansion,
chronic, fibrointimal arterial occlusion, and tubular atrophy!
dropout. Other findings were more frequent in patients with
CPDAF, but occurred too infrequently to be reliable indicators
of CPDAF. Glomerular basement membrane reduplication, for
example, was seen in 48% of the biopsies in patients with
CPDAF versus 18% of the biopsies in patients who maintained
stable allograft function (P < 0.05). The best overall indicator of
CPDAF was the composite CR score (fibrointimal arterial
narrowing + interstitial fibrosis + tubular atrophy + the per-
cent of glomeruli that were hyalinized + glomerular basement
membrane reduplication).
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Fig. 5. The area inside Bowman's capsule
(logarithmically transformed) in patients with
a chronic progressive decline in ailograft
function (CPDAF) (area is the logarithm of
square microns = 0.011 (1) + 8.5, where T =
months after transplantation, P < 0.001) and
in patients who maintained stable function
(area = 0.006 (T) + 8.7, P < 0.001). The
slopes were not different (P> 0.05),
indicating that the increases in glomerular
areas during the post-transplant period were
not significantly different in patients with and
without CPDAF.
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Table 6. Clinical and histopathologic findings associated with
proteinuria
Histopathologic features
Urine protein excretion >1.0 g124
hr at the time of biopsy
No (N 78) Yes (N = 21)
Interstitial edema 38 15 32 13
Interstitial cells 44 20 39 12
GlomeruJar mesangial 11 9 17 16
expansion
Chronic arterial intimal 32 25 46 23
thickening
Interstitial fibrosis 47 17 61 13"
Tubular atrophy 35 20 41 17
Basement membrane 7 (0—94) 31 (0-98)"
reduplication
Subepithelial deposits 0.0 (0) 0.1 (0—I Ø)t
Acute cellular rejection 82 31 71 18
scorec
Acute vascular rejection 14 (0—101) 23 (0—200)'
scored
Chronic rejection score 140 71 209 76"
Values are mean SD except where indicated, or in the case of
non-parametric data, ranges (in parentheses).
a P < 0.05; b p < 0.01
Acute cellular rejection and chronic rejection scores are defined in
Table 3
' Acute vascular rejection score is defined in Table 4
The results of the present investigation are in general agree-
ment with those of another recent study that examined the
relationship between histopathologic findings and combined
patient and graft survival [5]. In that study, features such as
fibrointimal thickening of arteries and arterioles were associ-
ated with a poor outcome. Interestingly, the increased inci-
dence of combined patient and graft loss associated with
chronic vascular lesions in that study was limited to the three
month period after the biopsy was obtained [5]. In the present
study, patients who underwent biopsy after the onset of
CPDAF survived with functioning allografts for 1.9 1.9 years
(95% confidence intervals = 1.2 to 2.6 years) after biopsy.
Thus, in the present investigation, the histologic lesions of CR
were seen in patients whose grafts continued to function for an
extended period of time. Moreover, there was a good correla-
tion between the severity of the CR biopsy findings and the
duration of subsequent allograft survival.
The pathogenesis of CR is unknown. Although immunologic
factors may be important, there is little evidence that CR is
entirely mediated by immunologic events [14, 20]. Recent
experimental data have suggested that a reduction in the
amount of functioning renal mass leads to compensatory
changes in the remaining intact nephrons that may ultimately be
injurious. Increases in single nephron glomerular filtration rate
and plasma flow, compensatory growth and hyperplasia of
intact nephrons, and other factors resulting from a reduced
nephron mass have been suggested to lead to progressive renal
injury [2 1—25].
In the present study, the size of intact glomeruli increased
with time after transplantation. Interestingly, the increase in
glomerular area did not seem to be confined to the immediate
post-transplant period (Fig. 5). Even more interesting was the
fact that the increase in the glomerular size was similar in
biopsies from patients with CPDAF compared to controls.
Table 7. Relationship (r values) between histopathologic features and
the subsequent allograft survival time in 46 patients who returned to
dialysis
Time remaining before
return to dialysis
Histopathologic features months
Interstitial edema 0.24
Interstitial cells —0.04
Glomerular mesangial
expansion
Chronic arterial intimal —0.44"
thickening
Interstitial fibrosis 0.54
Tubular atrophy
Acute cellular rejection scored 0.05
Chronic rejection scored
a P < b P < 0.01, P < 0.001
d Acute cellular rejection and chronic rejection scores are defined in
Table 3
Thus, it is difficult to implicate factors associated with compen-
satory growth and hyperplasia of residual glomeruli in the
pathogenesis of CPDAF. Why there was not a greater increase
in the size of intact glomeruli in patients with CPDAF is
unclear. However, it is possible that the fibrointimal vascular
occlusion associated with CR may have limited the normal,
compensatory, hypertrophic response.
Since intrarenal vascular disease is one of the most striking
features of CR, the relationship between known systemic
vascular disease risk factors and CR was carefully examined in
the present study. Hypertension was common and more severe
in patients with CR. To what extent the hypertension was a
cause and/or a result of the renal damage is unclear. However,
the fibrointimal occlusion associated with CR tended to be most
marked in large intrarenal arteries, In native kidneys, on the
other hand, hypertension characteristically affects smaller ar-
teries and arterioles [26, 27]. Thus, although hypertension may
have contributed to the fibrointimal vascular damage seen in
patients with CR, the prominent involvement of large intrarenal
arteries suggests that these lesions were not due to hyperten-
sion alone.
Proteinuria was also common in the present study, and
patients with proteinuria were more likely to have histologic
findings of CR. Whether proteinuria directly, or indirectly,
contributed to the development and progression of CR is
unknown. It is interesting to speculate, however, that increased
serum lipids associated with proteinuria could have contributed
to both glomerular and vascular damage in CR.
Regression analysis using clinical parameters measured at the
time of biopsy cannot distinguish potential causes from possible
consequences of CR. Thus, we can only speculate whether
clinical variables such as hypertension, hyperlipidemia and
proteinuria were important in the pathogenesis of CR. How-
ever, we examined the possible impact of other variables
measured before biopsy. Only the time of biopsy, the number of
acute rejection episodes before biopsy, and cigarette smoking at
the time of transplantation were independently correlated with
the histologic findings of CR. The association between cigarette
smoking and CR has not been previously reported, and pro-
vides further support to the hypothesis that risk factors for
systemic vascular disease may also be risk factors for CR.
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In a previous investigation of renal function after transplan-
tation, we found no clinical or laboratory parameters that were
reliable predictors of patients destined to develop CPDAF [161.
In the present study, the histologic findings of acute cellular
rejection and CR did not precede the onset of CPDAF. How-
ever, biopsies obtained before the onset of CPDAF were more
likely to have interstitial hemorrhage, a sign of severe, acute,
vascular rejection. These results are consistent with those of
another investigation that found patients who had severe acute
rejection episodes in the early post-transplant period were more
likely to develop chronic rejection [28]. Although it may cause
CR, acute vascular rejection occurs infrequently, and, thus,
heralds the onset of CPDAF in only a small number of patients.
In the present investigation, the best overall histologic cor-
relate to the degree of acute functional decline before biopsy
was the amount of interstitial edema. There was no correlation
between the amount of interstitial cellular infiltrate and the
magnitude of decline in renal function before biopsy. Similarly,
there was no difference in the degree of acute, interstitial, cell
infiltrate in patients who did or did not have CPDAF. These
results are in agreement with those oThthers who found that the
degree of acute, interstitial, cell infiltrate did not correlate with
the clinical course [1, 29].
The patients in the present study were treated with the same
conventional immunosuppression protocol. As a result it was
not possible to investigate the relative impact of the individual
immunosuppressive agents on allograft histology. Moreover,
since none of the patients in the present study received cyclo-
sporin A (CsA), the possible impact of CsA on the histopathol-
ogy of CR cannot be determined from these results. On the
other hand, the fact that none of the patients were treated with
CsA permits us to conclude that the histologic damage and
CPDAF were caused by immune and/or nonimmune mecha-
nisms unrelated to chronic CsA nephrotoxicity. In the future, it
may be difficult to clearly distinguish chronic intrarenal vascu-
lar damage and interstitial fibrosis caused by CsA from that
caused by CR.
In summary, the biopsy findings of CR were seen after, but
not before, the onset of CPDAF, suggesting that the histopa-
thology features of CR may not be useful in predicting CPDAF.
On the other hand, the results confirm that the histologic
features of CR were more common in patients with CPDAF,
and indicate that a histologic diagnosis of CR may be associated
with a very gradual deterioration in renal function. Thus, in
patients with CPDAF, a biopsy may be useful in confirming the
diagnosis of CR, and in excluding other causes of allograft
dysfunction. Moreover, the severity of the chronic histopatho-
logic changes may predict the duration of subsequent allograft
survival. Finally, the associations between hypertension, ciga-
rette smoking and CR suggest vascular disease risk factors
could be important in the pathogenesis of CR.
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